interferon alfa Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 2 (1)
Phase 4 (1)

Interventional (2)

Institute of Hematology & Blood Diseases Hospital (1)
Vir Biotechnology, Inc. (1)

No (2)

No (2)

Adult (18+) (1)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadchronic hepatitis

I am/have/hadthrombocytosis

I am/have/hadessential thrombocythemia

I am/have/hadATM

I am/have/hadplatelet count

I am/have/hadhepatitis

added new label for I am/have/had

more

I am looking for

I am looking forpeginterferon alfa-2b

I am looking forinterferon

I am looking forantiviral drugs

I am looking forinterferon alfa

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 4
For pediatric ages
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in the Treatment of Childhood Essential Thrombocythemia

Objectives: To compare the efficacy and safety in children (<18 years) diagnosed as essential thrombocythemia treated with the Pegylated Interferon Alfa-2b vs. Interferon Alfa. Study Design: A prospective, open-label, nonrandomized, single-center clinical trial

thrombocytosis

essential thrombocythemia

interferon

peginterferon alfa-2b

interferon alfa

0 views
16 Feb, 2024
1 location

Multi-country trial
Phase 2
For adults
Recruiting in 100s
Interventional Study
all
Gastroenterology
Recruiting

Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus Infection

This is a phase 2 study in which subjects with chronic hepatitis B virus (HBV) infection will receive VIR-2218 alone or in combination with pegylated interferon alfa-2a and will be assessed for safety, tolerability, pharmacokinetics, and antiviral activity.

chronic hepatitis

hepatitis

interferon

antiviral drugs

0 views
16 Feb, 2024
18 locations

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.